UNIVERSITY OF CINCINNATI

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1819-01-01

Employees: 5.9K

Market Cap: -

Website: https://www.uc.edu/

Clinical Trials

An Eval of Neurocognitive Function, Oxidative Damage, and Their Association With Outcomes in METH and Cocaine Abusers.

Completed

Conditions: Stimulant Dependence

First Posted Date: 2008-03-05

Last Posted Date: 2015-12-30

Lead Sponsor: University of Cincinnati

Target Recruit Count: 217

Registration Number: NCT00628927

Locations: 🇺🇸
Gateway Community Services, Jacksonville, Florida, United States
🇺🇸
Maryhaven, Columbus, Ohio, United States
🇺🇸
ChangePoint, Inc., Portland, Oregon, United States

and more 3 locations

Effect of High Monounsaturated Fat Diet on Glycemic Control and Cardiovascular Risk Factors in Type 2 Diabetes

Phase 1

Completed

Conditions: Overweight
Obesity
Type 2 Diabetes

Interventions: Other: High-MUFA diet
Other: High-CHO diet

First Posted Date: 2008-02-25

Last Posted Date: 2008-02-25

Lead Sponsor: University of Cincinnati

Target Recruit Count: 124

Registration Number: NCT00622960

Locations: 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States

Assess Safety and Efficacy of Levetiracetam(LEV;Keppra)for Seizure Prevention

Phase 4

Completed

Conditions: Traumatic Brain Injury
Subarachnoid Hemorrhage

Interventions: Drug: Phenytoin
Drug: Levetiracetam

First Posted Date: 2008-02-20

Last Posted Date: 2014-04-07

Lead Sponsor: University of Cincinnati

Target Recruit Count: 52

Registration Number: NCT00618436

Locations: 🇺🇸
University of Cincinnati Hospital, Cincinnati, Ohio, United States

Community Reinforcement and Family Training for Drug Abuse Treatment Retention/HIV Risk Reduction

Phase 1

Conditions: Heroin Dependence
Opiate Dependence
Substance Dependence

Interventions: Behavioral: CRAFT-T
Behavioral: Treatment as usual

First Posted Date: 2008-02-06

Last Posted Date: 2012-08-14

Lead Sponsor: University of Cincinnati

Target Recruit Count: 104

Registration Number: NCT00609089

Locations: 🇺🇸
Maryhaven, Columbus, Ohio, United States

Functional and Neurochemical Brain Changes in First-episode Bipolar Mania

Completed

Conditions: Bipolar Disorder

Interventions: Drug: lithium
Drug: quetiapine

First Posted Date: 2008-02-06

Last Posted Date: 2015-12-07

Lead Sponsor: University of Cincinnati

Target Recruit Count: 81

Registration Number: NCT00609193

Locations: 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States

Neurofunctional and Neurochemical Markers of Treatment Response in Bipolar Disorder

Phase 4

Conditions: Bipolar I Disorder

Interventions: Drug: Lithium

First Posted Date: 2008-02-06

Last Posted Date: 2016-10-06

Lead Sponsor: University of Cincinnati

Target Recruit Count: 260

Registration Number: NCT00608075

Locations: 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States

Study of Duloxetine vs Placebo in Treatment of Binge Eating Disorder With Depression

Phase 4

Completed

Conditions: Binge Eating
Depression

Interventions: Drug: Placebo
Drug: Duloxetine

First Posted Date: 2008-02-06

Last Posted Date: 2017-08-21

Lead Sponsor: University of Cincinnati

Target Recruit Count: 40

Registration Number: NCT00607789

Locations: 🇺🇸
University of Cincinnati and Lindner Center of HOPE, Cincinnati, Ohio, United States

Functional and Neurochemical Brain Changes Bipolar Depression

Completed

Conditions: Depression, Bipolar

First Posted Date: 2008-02-06

Last Posted Date: 2014-12-23

Lead Sponsor: University of Cincinnati

Target Recruit Count: 120

Registration Number: NCT00608296

Locations: 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States

Safety Assessment of Potential Interactions Between IV Methamphetamine and Osmotic-Release Methylphenidate (OROS-MPH)

Phase 1

Completed

Conditions: Methamphetamine Dependence
Methamphetamine Abuse

Interventions: Drug: OROS-MPH

First Posted Date: 2008-01-29

Last Posted Date: 2017-01-12

Lead Sponsor: University of Cincinnati

Target Recruit Count: 16

Registration Number: NCT00603434

Locations: 🇺🇸
Cincinnati Addiction Research Center, Cincinnati, Ohio, United States
🇨🇦
Ventana Clinical Research Corporation, Toronto, Ontario, Canada

A Study of Amifostine (Ethyol) in Patients With Colorectal Cancer

Phase 2

Terminated

Conditions: Colorectal Cancer

Interventions: Drug: Amifostine

First Posted Date: 2008-01-25

Last Posted Date: 2023-08-01

Lead Sponsor: University of Cincinnati

Target Recruit Count: 4

Registration Number: NCT00601198

Locations: 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy